Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06203054 · ClinicalTrials.gov registry record · NA
CLIP-IT Post-Market Study
A NA study of Left Atrial Appendage Exclusion, sponsored by Medtronic Cardiac Surgery.
- Active
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 15
- Study locations
NCT06203054 is a NA study of Left Atrial Appendage Exclusion that is active but no longer recruiting, run by Medtronic Cardiac Surgery. The registered enrollment target is 150 participants. The trial reports 15 study locations across 11 states.
The verdict
NCT06203054, a NA study of Left Atrial Appendage Exclusion, is active but no longer recruiting, sponsored by Medtronic Cardiac Surgery.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 15
- Study locations
Study Summary
The purpose of this study is to collect post-market clinical evidence on performance and clinical outcomes of the Penditure™ Left Atrial Appendage (LAA) Exclusion System in subjects undergoing concomitant cardiac surgery.
Conditions Studied
Interventions
- DEVICE Penditure™ Left Atrial Appendage (LAA) Exclusion System
Study Locations (15)
Pennsylvania
- UPMC Pinnacle Harrisburg Campus - Harrisburg
- University of Pittsburgh Medical Center UPMC Presbyterian - Pittsburgh
- Lankenau Institute for Medical Research - Wynnewood
Michigan
- University of Michigan Health System - Ann Arbor
- Corewell Health - Grand Rapids
Ohio
- University Hospitals Cleveland Medical Center - Cleveland
- ProMedica Toledo Hospital - Toledo
Georgia
- Emory Saint Joseph's Hospital - Atlanta
Illinois
- Northwestern Memorial Hospital - Chicago
Indiana
- Ascension St. Vincent Heart Center - Carmel
Minnesota
- Mayo Clinic Saint Marys Campus - Rochester
Missouri
- Barnes Jewish Hospital - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2024-02-26 |
| Est. Completion | 2029-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06203054
The ClinicalTrials.gov registry entry for NCT06203054 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiac Surgery, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Left Atrial Appendage Exclusion appearing as the primary indexed condition, and to 1 intervention - of which Penditure™ Left Atrial Appendage (LAA) Exclusion System is the first listed.
NCT06203054 reports 15 study locations spanning 11 distinct geographic areas - top geographies include Pennsylvania, Michigan, Ohio.
Frequently Asked Questions
What is clinical trial NCT06203054 about?
NCT06203054 is a clinical study titled "CLIP-IT Post-Market Study". The purpose of this study is to collect post-market clinical evidence on performance and clinical outcomes of the Penditure™ Left Atrial Appendage (LAA) Exclusion System in subjects undergoing concomitant cardiac surgery.
What is the current status of trial NCT06203054?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2024-02-26. Estimated completion is 2029-02.
What conditions does trial NCT06203054 study?
This clinical trial studies the following conditions: Left Atrial Appendage Exclusion.
What interventions are being tested in trial NCT06203054?
The interventions under investigation include: Penditure™ Left Atrial Appendage (LAA) Exclusion System (DEVICE).
Who is sponsoring clinical trial NCT06203054?
This trial is sponsored by Medtronic Cardiac Surgery, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06203054 being conducted?
This trial has 15 study locations across Georgia, Illinois, Indiana, Michigan, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.